ACE2 and COVID-19: The osmotic crisis resulting from hypokalemia and disruption of the ACE2-based complex is compatible with clinical findings in damaged endothelial cells, early manifestations of elevated D-dimer levels, and the progression to thrombosis in COVID-19 patients.